Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS)
INR 56.84
(0.0%)
INR 56.84
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 3.95 Billion | 4.14 Billion | 4.91 Billion | 3.47 Billion | 3 Billion | 3.54 Billion |
| Cost of Revenue | 3.84 Billion | 4.03 Billion | 4.72 Billion | 3.37 Billion | 2.9 Billion | 3.4 Billion |
| Gross Profit | 113.02 Million | 104.12 Million | 195.44 Million | 100.98 Million | 99.07 Million | 137.32 Million |
| Operating Expenses | 14.21 Million | 89.62 Million | 100.86 Million | 63.73 Million | 75.52 Million | 68.32 Million |
| Selling, General and Administrative Expenses | 14.21 Million | 20.1 Million | 10.02 Million | 4.81 Million | 6.35 Million | 3.89 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 137.19 Million | 74.32 Million | 5.84 Million | 45.82 Million | 40.24 Million | 22.35 Million |
| Cost and Expenses | 3.95 Billion | 4.12 Billion | 4.82 Billion | 3.44 Billion | 2.97 Billion | 3.47 Billion |
| Operating Income | 2.83 Million | 66.92 Million | 100.26 Million | 82.3 Million | 63.53 Million | 91.29 Million |
| Interest Expense | - | 28.67 Million | 19.12 Million | 23.18 Million | 16.86 Million | 21.41 Million |
| Income Tax Expense | 6.59 Million | 22.38 Million | 34.82 Million | 17.87 Million | 14.48 Million | 24.44 Million |
| Earnings before Tax | 53.42 Million | 60.15 Million | 100.27 Million | 83.01 Million | 72.42 Million | 89.86 Million |
| Net Income | 46.83 Million | 37.71 Million | 65.54 Million | 65.14 Million | 57.93 Million | 65.41 Million |
| Earnings Per Share Basic | 1.84 | 1.49 | 2.72 | 2.79 | 2.48 | 2.80 |
| Earnings Per Share Diluted | 1.84 | 1.49 | 2.72 | 2.79 | 2.48 | 2.80 |
| Weighted Average Shares Outstanding | 25.41 Million | 25.38 Million | 24.07 Million | 23.38 Million | 23.38 Million | 23.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.41 Million | 25.38 Million | 24.07 Million | 23.38 Million | 23.38 Million | 23.38 Million |
| Gross Margin | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | 0.04 |
| EBIT Margin | 0.01 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Profit Margin | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 |
| EBITDA | 45.16 Million | 82.65 Million | 120.14 Million | 91.5 Million | 72.47 Million | 101.37 Million |
| Earnings Before Tax Margin | 0.00 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 1.26 Billion | 3.95 Billion | 2.1 Billion | 764.76 Million | 578.31 Million | 509.56 Million |
| Cost of Revenue | 1.24 Billion | 3.84 Billion | 2.06 Billion | 733.4 Million | 551.7 Million | 480.06 Million |
| Gross Profit | 27.13 Million | 113.02 Million | 36.04 Million | 31.36 Million | 26.6 Million | 29.49 Million |
| Operating Expenses | 20.01 Million | 85.49 Million | 54.42 Million | 9.05 Million | 12.23 Million | 20.26 Million |
| Selling, General and Administrative Expenses | 20.01 Million | - | 54.42 Million | 9.05 Million | 3.12 Million | 8.29 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 15.75 Million | 69.64 Million | 51.38 Million | 2.93 Million | 8.35 Million | 6.97 Million |
| Cost and Expenses | 1.26 Billion | 3.92 Billion | 2.12 Billion | 742.45 Million | 563.93 Million | 500.33 Million |
| Operating Income | 7.12 Million | 27.53 Million | -18.38 Million | 22.31 Million | 22.73 Million | 9.22 Million |
| Interest Expense | 9.57 Million | 43.75 Million | 11.54 Million | 10.59 Million | 12.66 Million | 8.94 Million |
| Income Tax Expense | 918 Thousand | 6.59 Million | -58 Thousand | -4.42 Million | 2.22 Million | 6.96 Million |
| Earnings before Tax | 13.3 Million | 53.42 Million | 21.46 Million | 14.65 Million | 10.06 Million | 7.24 Million |
| Net Income | 12.39 Million | 46.83 Million | 21.51 Million | 19.07 Million | 7.84 Million | 7.24 Million |
| Earnings Per Share Basic | 0.44 | - | 0.77 | 0.75 | 0.31 | 0.29 |
| Earnings Per Share Diluted | 0.44 | - | 0.77 | 0.75 | 0.31 | 0.29 |
| Weighted Average Shares Outstanding | 28.05 Million | 28.05 Million | 25.38 Million | 25.38 Million | 25.38 Million | 25.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 28.05 Million | 28.05 Million | 25.38 Million | 25.38 Million | 25.38 Million | 25.38 Million |
| Gross Margin | 0.02 | 0.03 | 0.02 | 0.04 | 0.05 | 0.06 |
| EBIT Margin | 0.01 | - | -0.01 | 0.04 | 0.05 | 0.04 |
| Profit Margin | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 |
| EBITDA | 11.78 Million | - | -14.38 Million | 27.03 Million | 26.83 Million | 20.35 Million |
| Earnings Before Tax Margin | 0.01 | 0.01 | -0.01 | 0.03 | 0.04 | 0.02 |
SUGALDAM
SHIVAGR
HAR
EKH
3611
PGM